Intermarket Securities Limited (PSX:IMS)

CTI BioPharma Ratios and Metrics

Market cap in millions PKR. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023
Period Ending	Jul 31, 2025	Dec 31, 2024	Dec 31, 2023
Market Capitalization	16,274	3,725	-
Last Close Price	12.64	7.10	-
PE Ratio	30.07	7.73	-
PS Ratio	13.14	3.38	-
PB Ratio	9.63	2.32	-
P/FCF Ratio	1072.12	8.19	-
P/OCF Ratio	458.71	8.00	-
Debt / Equity Ratio	0.55	0.37	0.36
Debt / FCF Ratio	61.62	1.31	-
Asset Turnover	-	0.36	-
Quick Ratio	1.27	0.92	1.44
Current Ratio	1.60	1.55	1.76
Return on Equity (ROE)	-	37.48%	-
Return on Assets (ROA)	-	15.78%	-
Earnings Yield	3.20%	12.95%	-
FCF Yield	0.09%	12.21%	-
Dividend Yield	1.58%	2.82%	-
Payout Ratio	0.01%	0.01%	-
Buyback Yield / Dilution	-	-9.20%	-
Total Shareholder Return	1.74%	-6.39%	-

Source: S&P Global Market Intelligence. Capital Markets template. Financial Sources.